Imiquimod nanocrystal-loaded dissolving microneedles prepared by DLP printing
Drug Delivery and Translational Research · 2025-01 · 15 (1) · 158-170
DOI: 10.1007/s13346-024-01567-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 12.03.2024. Verfasst von Eliška Petrová und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, UK. Hauptthemen laut MEDLINE: Imiquimod, Needles, Nanoparticles, Printing, Three-Dimensional. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The utilization of 3D printing– digital light processing (DLP) technique, for the direct fabrication of microneedles encounters the problem of drug solubility in printing resin, especially if it is predominantly composed of water. The possible solution how to ensure ideal belonging of drug and water-based printing resin is its pre-formulation in nanosuspension such as nanocrystals. This study investigates the feasibility of this approach on a resin containing nanocrystals of imiquimod (IMQ), an active used in (pre)cancerous skin conditions, well known for its problematic solubility and bioavailability. The resin blend of polyethylene glycol diacrylate and N-vinylpyrrolidone, and lithium phenyl-2,4,6-trimethylbenzoylphosphinate as a photoinitiator, was used, mixed with IMQ nanocrystals in water. The final microneedle-patches had 36 cylindrical microneedles arranged in a square grid, measuring approximately 600 μm in height and 500 μm in diameter. They contained 5wt% IMQ, which is equivalent to a commercially available cream. The homogeneity of IMQ distribution in the matrix was higher for nanocrystals compared to usual crystalline form. The release of IMQ from the patches was determined ex vivo in natural skin and revealed a 48% increase in efficacy for nanocrystal formulations compared to the crystalline form of IMQ. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, UK.
- Department of Organic Technology, University of Chemistry and Technology Prague, Faculty of Chemical Technology, Technická 5, 166 28, Prague 6, Czech Republic.
- Faculty of Chemical Technology, Department of Organic Technology, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague, Czech Republic.
- Department of Organic Technology, University of Chemistry and Technology Prague, Faculty of Chemical Technology, Technická 5, 166 28, Prague 6, Czech Republic. jarmila.zbytovska@vscht.cz.
- School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, BT9 7BL, Belfast, UK. d.lamprou@qub.ac.uk.
ORCID-Profile: Eliška Petrová, Stanislav Chvíla, František Štěpánek, Jarmila Zbytovská, Dimitrios A Lamprou
Zitieren
APA
Petrová, E., Chvíla, S., Štěpánek, F., Zbytovská, J., & Lamprou, D. A. (2025). Imiquimod nanocrystal-loaded dissolving microneedles prepared by DLP printing. Drug Delivery and Translational Research, 15(1), 158-170. https://doi.org/10.1007/s13346-024-01567-0
Vancouver
Petrová E, Chvíla S, Štěpánek F, Zbytovská J, Lamprou DA. Imiquimod nanocrystal-loaded dissolving microneedles prepared by DLP printing. Drug Delivery and Translational Research. 2025;15(1):158-170. doi:10.1007/s13346-024-01567-0
BibTeX
@article{Petrov2025,
author = {Petrová, Eliška and Chvíla, Stanislav and Štěpánek, František and Zbytovská, Jarmila and Lamprou, Dimitrios A},
title = {Imiquimod nanocrystal-loaded dissolving microneedles prepared by DLP printing},
journal = {Drug Delivery and Translational Research},
year = {2025},
volume = {15},
number = {1},
pages = {158--170},
doi = {10.1007/s13346-024-01567-0}
}
EUVIMED